Pharmacytimes offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Thu, 19 Jan 17 23:32:34 +0000 Thu, 19 Jan 17 23:32:34 +0000 FDA Approves Oral Treatment for Chronic Idiopathic Constipation The FDA announced the approval of Trulance (plecanatide), Synergy&rsquo;s once-daily oral treatment for chronic idiopathic constipation (CIC) in adult patients. Thu, 19 Jan 17 22:18:01 +0000 Topical Treatment for Facial Redness Receives FDA Approval The FDA has approved Allergan&rsquo;s newest topical treatment for persistent facial erythema.&nbsp; Thu, 19 Jan 17 21:20:24 +0000 FDA Approves Generic Oral Treatment for Narcolepsy The FDA has approved the first generic version of Xyrem (sodium oxybate) oral solution for patients with narcolepsy under strict safety requirements.&nbsp; Thu, 19 Jan 17 17:49:40 +0000 Oxy Trafficking Scheme Lands Man Five-Year Imprisonment Sentence A man was recently sentenced to 57 months of imprisonment for his involvement in a drug trafficking organizations&rsquo; conspiracy scheme.&nbsp;<br /> &nbsp; Thu, 19 Jan 17 15:58:50 +0000 Cannabidiol Chewing Gum Assessed as Possible IBS Treatment Developed by leading cannabinoid research and development company Axim Biotech, the cannabidiol (CBD) gum is designed to alleviate symptoms of IBS.&nbsp; Thu, 19 Jan 17 14:13:58 +0000 FDA Approves Opioid Treatment The FDA has approved Teva&rsquo;s Vantrela ER (hydrocodone bitartrate) extended-release tablets. Wed, 18 Jan 17 21:07:56 +0000 Partial ACA Repeal Could Leave Up to 32 Million Uninsured, Report Estimates Amidst recent efforts to dismantle the Affordable Care Act, a newly-released report has suggested that repealing several provisions of the health reform law could potentially raise premiums and leave millions of Americans without health insurance coverage. Wed, 18 Jan 17 20:50:22 +0000 Biosimilar Interchangeability Subject of FDA Document Requirements will vary based on the nature of the proposed interchangeable product, and may include an evaluation of data and information generated to support a demonstration of a biological product&rsquo;s biosimilarity. Wed, 18 Jan 17 13:25:02 +0000 ADHD Candidate Drug Did Not Meet Primary Endpoint The drug failed to demonstrate&nbsp;a statistically significant difference from placebo in the change from baseline of the investigator rating of the Conners&rsquo; Adult ADHD Rating Scales (CAARS). Tue, 17 Jan 17 19:31:18 +0000 Drug Shortage Prompts FDA to Allow Use of EU-Approved Product The FDA is allowing the sale of EU-approved Panretin gel (alitretinoin 0.1%) tubes in the United States due to a shortage of the US-approved gel. Tue, 17 Jan 17 19:20:25 +0000 Murder Trial Begins for Pharmacist Over Meningitis Outbreak Five years after the deadly outbreak, the owner and former head pharmacist of the NECC faces charges for racketeering, mail fraud, and murder.&nbsp; Tue, 17 Jan 17 16:53:47 +0000 ACP, AAFP Release Joint Updated Hypertension Guidelines The new guidelines put forth a looser diagnostic treatment threshold for average and low-risk adults.&nbsp; Tue, 17 Jan 17 16:13:00 +0000 Legislation Urging Pharmacists to Provide Elderly Care Introduced in Senate This popular bipartisan legislation aims to increase access to health care in rural areas.&nbsp; Tue, 17 Jan 17 14:33:39 +0000 CDC Urges Improved Health Care for Rural Americans Mon, 16 Jan 17 20:34:49 +0000 FDA Approves Investigational New Drug Application for Ceramide NanoLiposome The FDA has approved&nbsp;the investigational new drug application from Keystone Nano for Ceramide NanoLiposome to assess the product as a form of treatment for solid tumors.&nbsp; Sat, 14 Jan 17 18:26:50 +0000 As Efforts to Repeal ACA Continue, Report Notes Prescription Drug Benefit of Program The Department of Health and Human Services has released information that shows that millions of seniors and people with disabilities with Medicare continue to save on prescription drugs and see improved benefits in 2016 as a result of the Affordable Care Act.&nbsp;<br /> &nbsp; Sat, 14 Jan 17 14:55:40 +0000 NeuroRx to Proceed with Study for Investigational ASIB Drug The FDA has given clearance&nbsp;to NeuroRx to proceed with a phase 2B/3 study protocol under an investigational new drug application for NRX-101, the first oral therapy for acute suicidal ideation and behavior (ASIB).&nbsp; Sat, 14 Jan 17 13:00:00 +0000 Hospital Fined $510,000 After Pharmacist's Illicit Prescription Drug Diversion A Pennsylvania hospital has agreed to pay $510,000 in fines after an inpatient pharmacist stole controlled substances.&nbsp; Fri, 13 Jan 17 20:13:53 +0000 Landmark Report Weighs in On Marijuana's Health Effects A new report released by the National Academies of Sciences, Engineering, and Medicine (NAS) sets forth an objective offering of key evidence surrounding the benefits and harms of cannabis use.&nbsp; Fri, 13 Jan 17 19:13:27 +0000 Advocates Celebrate Medicare Nod to CGMs for Diabetes Treatment Decisions Continuous glucose monitors (CGMs) may soon be eligible for coverage by the US Centers for Medicare and Medicaid Services (CMS).&nbsp; Fri, 13 Jan 17 15:34:58 +0000 FDA: Avoid PNC-27, Discuss Approved Treatment Options with Providers The FDA has not issued an approval for the drug and it is not indicated to treat any conditions. Thu, 12 Jan 17 16:52:13 +0000 NCPA Identifies Essential ACA Provisions in Recommendations to Congress As President-elect Donald Trump and congressional Republicans prepare their efforts to dismantle the Affordable Care Act, the NCPA has penned a letter to key representatives outlining its recommendations for future health care reform. Thu, 12 Jan 17 15:30:59 +0000 Child Vaccinations, Smoking Prevention Ranked Highest Among Preventive Services Other highly ranked services included alcohol screening, aspirin therapy for cardiovascular disease prevention, and colorectal cancer screening. Thu, 12 Jan 17 14:23:45 +0000 Fast Track Designation for Refractory CMV After Transplant Treatment The FDA has granted&nbsp;fast track designation to ViraCyte for Viralym-C, its T-cell immunotherapy product indicated to treat refractory cytomegalovirus after a patient has received a stem cell transplant.<br /> &nbsp; Tue, 10 Jan 17 15:55:52 +0000 Long-Acting Opioid for Patients With Severe Pain Gets FDA Nod The FDA has approved morphine sulfate extended-release tablets (Arymo ER,&nbsp;Egalet Corporation), a long-term opioid treatment for pain management in cases where&nbsp;alternative treatment options may be&nbsp;inadequate Mon, 09 Jan 17 20:01:19 +0000